Boston Immune Technologies & Therapeutics

BiotechnologySeries AUSbostonimmunetech.com
See the investorsFind investors for my raise

Latest round

Series A

Last raised

Mar 2021

Total raised

$10M

Investors

2

About Boston Immune Technologies & Therapeutics

Founded in 2011 and based in Virginia, US, Boston Immune Technologies & Therapeutics, Inc. operates as a developer of novel TNF (tumor necrosis factor) superfamily antagonist antibodies. Boston Immune Technologies & Therapeutics, Inc. develops tumor necrosis factor receptor superfamily antibodies including CD40 antagonists for inflammation and CD30 antagonists for oncology.

Who invested in Boston Immune Technologies & Therapeutics

2 investors across 1 round

See all investors in Boston Immune Technologies & Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Mar 17, 2021

    Amount

    $10M

    Investors

    Locked

Questions about Boston Immune Technologies & Therapeutics

Who invested in Boston Immune Technologies & Therapeutics?

Boston Immune Technologies & Therapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Boston Immune Technologies & Therapeutics raised?

Boston Immune Technologies & Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Boston Immune Technologies & Therapeutics last raise money?

Boston Immune Technologies & Therapeutics's most recent round on record is a Series A, in Mar 2021.

What does Boston Immune Technologies & Therapeutics do?

Founded in 2011 and based in Virginia, US, Boston Immune Technologies & Therapeutics, Inc.

Where is Boston Immune Technologies & Therapeutics headquartered?

Boston Immune Technologies & Therapeutics is headquartered in US.

Which VCs invest in companies like Boston Immune Technologies & Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Boston Immune Technologies & Therapeutics's stage. Their profiles are linked below.

VCs backing biotechnology startups at Series A

Andreessen HorowitzUS · Cheque $3.8M–$81.3M$21.5B dry powderFounders FundUS · Cheque $696K–$57.5M$10.8B dry powderAccelUS · Cheque $1.1M–$31.9M$9.4B dry powderThrive CapitalUS · Cheque $225K–$30.6M$8.9B dry powderKleiner PerkinsUS · Cheque $2M–$32.5M$4.5B dry powderLightspeed Venture PartnersUS · Cheque $1.7M–$35.8M$4B dry powder

Raising like Boston Immune Technologies & Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.